Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2025 ,inter alia, to consider and approve PFA
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed stock exchanges that its Board of Directors will meet on Thursday, 22 May 2025. The main agenda is to approve and take on record the Audited Standalone Financial Results for the quarter and financial year ended 31 March 2025. The notice was issued on 12 May 2025 under SEBI LODR Regulation 29. The company is listed on BSE (Scrip Code: 539470), Calcutta Stock Exchange, and Metropolitan Stock Exchange. Any additional matters may also be discussed with board approval.
This is a routine pre-results intimation. Investors should watch for the audited FY25 results announcement, which will be released after the board meeting and could influence the stock price depending on the company's earnings performance.